BioSpace News Archive

Genetown

CervoMed to Present at H.C. Wainwright 25th Annual Global Investment Conference

CervoMed Inc., a clinical-stage company focused on developing treatments for degenerative diseases of the brain, announced that the Company’s senior management team will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11 at 9:00 a.m. ET.

September 5, 2023

·

4 min read

Genetown

Remix Therapeutics to Participate in Upcoming September 2023 Investor Conferences

Remix Therapeutics, a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, announced that management will participate in several upcoming investor conferences.

September 5, 2023

·

1 min read

Business

Didier Landais is appointed 4P-Pharma’s CEO to lead the company into a new chapter of its development

4P-Pharma is thrilled to achieve a significant milestone in its history.

September 5, 2023

·

4 min read

Baird Medical’s Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China

Baird Medical Investment Holdings Limited announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., has received approval of its Single-Use Sterile Biopsy Needle from Jiangsu Medical Products Administration, the drug regulatory body for Jiangsu Province in China.

September 5, 2023

·

2 min read

Italfarmaco Group Receives EMA Validation of Marketing Authorization Application for Givinostat in Duchenne Muscular Dystrophy

Italfarmaco Group announced that its Marketing Authorization Application for Givinostat as a potential treatment for Duchenne Muscular Dystrophy has been submitted to the European Medicine Agency and that the EMA has started its regulatory review process.

September 5, 2023

·

4 min read

Policy

Viatris Announces U.S. FDA Tentative Approval of a Paediatric Formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC), a Once-daily Treatment for Children Living with HIV

Viatris Inc., a global healthcare company, announced U.S. Food and Drug Administration tentative approval for a New Drug Application for abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension for the treatment of HIV-1 infection in paediatric patients.

September 5, 2023

·

16 min read

Business

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Zenas BioPharma announced that it has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialize obexelimab for autoimmune diseases in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia.

September 5, 2023

·

4 min read

Bio NC

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

ProKidney Corp. announced that Dr. Tim Bertram, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, being held in New York, NY from September 11 – 14, 2023.

September 5, 2023

·

5 min read

Business

Aesthetic Medical International Reports First Half of 2023 Unaudited Financial Results

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announced its unaudited financial results for the six months ended June 30, 2023.

September 5, 2023

·

18 min read

Biotech Bay

IDEAYA Biosciences to Participate in Upcoming September 2023 Investor Relations Events

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events.

September 5, 2023

·

2 min read